These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients. Chen H; Liu W; Wang Y; Liu D; Zhao L; Yu J EBioMedicine; 2021 Aug; 70():103500. PubMed ID: 34311326 [TBL] [Abstract][Full Text] [Related]
6. Long-Term Modeling of SARS-CoV-2 Infection of Hao S; Ning K; Kuz CA; Vorhies K; Yan Z; Qiu J mBio; 2020 Nov; 11(6):. PubMed ID: 33158999 [TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 infection activates a subset of intrinsic pathways to inhibit type I interferons Luo W; Huang L; Wang X; Ma Y; Xiao J; Song X; Liu P; Wang Y; Wang Y; Ren Z Int J Med Sci; 2021; 18(12):2561-2569. PubMed ID: 34104087 [TBL] [Abstract][Full Text] [Related]
8. The SARS-CoV-2 Transcriptome and the Dynamics of the S Gene Furin Cleavage Site in Primary Human Airway Epithelia. Zou W; Xiong M; Hao S; Zhang EY; Baumlin N; Kim MD; Salathe M; Yan Z; Qiu J mBio; 2021 May; 12(3):. PubMed ID: 33975939 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells. Jiang M; Kolehmainen P; Kakkola L; Maljanen S; Melén K; Smura T; Julkunen I; Österlund P Microbiol Spectr; 2021 Sep; 9(1):e0077421. PubMed ID: 34378952 [TBL] [Abstract][Full Text] [Related]
12. Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children. Loske J; Röhmel J; Lukassen S; Stricker S; Magalhães VG; Liebig J; Chua RL; Thürmann L; Messingschlager M; Seegebarth A; Timmermann B; Klages S; Ralser M; Sawitzki B; Sander LE; Corman VM; Conrad C; Laudi S; Binder M; Trump S; Eils R; Mall MA; Lehmann I Nat Biotechnol; 2022 Mar; 40(3):319-324. PubMed ID: 34408314 [TBL] [Abstract][Full Text] [Related]
13. Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus. Qian Z; Travanty EA; Oko L; Edeen K; Berglund A; Wang J; Ito Y; Holmes KV; Mason RJ Am J Respir Cell Mol Biol; 2013 Jun; 48(6):742-8. PubMed ID: 23418343 [TBL] [Abstract][Full Text] [Related]
14. Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2. Hatton CF; Botting RA; Dueñas ME; Haq IJ; Verdon B; Thompson BJ; Spegarova JS; Gothe F; Stephenson E; Gardner AI; Murphy S; Scott J; Garnett JP; Carrie S; Powell J; Khan CMA; Huang L; Hussain R; Coxhead J; Davey T; Simpson AJ; Haniffa M; Hambleton S; Brodlie M; Ward C; Trost M; Reynolds G; Duncan CJA Nat Commun; 2021 Dec; 12(1):7092. PubMed ID: 34876592 [TBL] [Abstract][Full Text] [Related]
15. Variability of interferon-λ induction and antiviral activity in Nipah virus infected differentiated human bronchial epithelial cells of two human donors. Sauerhering L; Müller H; Behner L; Elvert M; Fehling SK; Strecker T; Maisner A J Gen Virol; 2017 Oct; 98(10):2447-2453. PubMed ID: 28984239 [TBL] [Abstract][Full Text] [Related]
16. Transcriptomic analysis reveals novel mechanisms of SARS-CoV-2 infection in human lung cells. Yang S; Wu S; Yu Z; Huang J; Zhong X; Liu X; Zhu H; Xiao L; Deng Q; Sun W Immun Inflamm Dis; 2020 Dec; 8(4):753-762. PubMed ID: 33124193 [TBL] [Abstract][Full Text] [Related]